vs
Side-by-side financial comparison of Citius Pharmaceuticals, Inc. (CTXR) and TOP Financial Group Ltd (TOP). Click either name above to swap in a different company.
Citius Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.9M, roughly 1.4× TOP Financial Group Ltd). TOP Financial Group Ltd runs the higher net margin — 6.6% vs -238.2%, a 244.8% gap on every dollar of revenue.
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative prescription therapies addressing unmet medical needs across critical care, oncology, anti-infective treatment, and supportive care segments, primarily serving the U.S. healthcare market.
Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.
CTXR vs TOP — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $3.9M | $2.9M |
| Net Profit | $-9.4M | $190.5K |
| Gross Margin | 80.0% | — |
| Operating Margin | -228.7% | — |
| Net Margin | -238.2% | 6.6% |
| Revenue YoY | — | — |
| Net Profit YoY | 8.6% | — |
| EPS (diluted) | $-0.38 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.7M | $14.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $80.0M | $35.0M |
| Total Assets | $140.4M | $64.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.7M | — | ||
| Q3 25 | — | $14.8M |
| Q4 25 | $80.0M | — | ||
| Q3 25 | — | $35.0M |
| Q4 25 | $140.4M | — | ||
| Q3 25 | — | $64.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-13.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-13.0M | — | ||
| Q3 25 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.